HR4299Referred to Committee
Protecting Patient Access to Cancer and Complex Therapies Act
Introduced
In Committee
3
Passed One Chamber4
Passed Both5
Signed into Law119th
Congress
2025-07-07
Introduced
31
Cosponsors
HR
ⓘType
Sponsor
Gregory F. Murphy
Republican · NC · Representative
Votes with party: 98.9% (468 recorded votes)
Full profile: /officials/M001210
Source: Congress.gov · FEC
Cosponsors (31)
Members who have signed on to support this bill since introduction. Source: Congress.gov.
- Adam Gray (D-CA-13)Original· 2025-07-07
- Neal P. Dunn (R-FL-2)Original· 2025-07-07
- Earl L. "Buddy" Carter (R-GA-1)· 2025-07-29
- John Joyce (R-PA-13)· 2025-09-04
- Carol D. Miller (R-WV-1)· 2025-10-08
- Andy Harris (R-MD-1)· 2025-10-24
- Thomas H. Kean, Jr. (R-NJ-7)· 2025-10-24
- David Kustoff (R-TN-8)· 2025-10-28
- Mariannette Miller-Meeks (R-IA-1)· 2025-10-28
- Max L. Miller (R-OH-7)· 2025-10-28
- Troy Balderson (R-OH-12)· 2025-10-31
- Mike Kennedy (R-UT-3)· 2025-11-12
- Brian K. Fitzpatrick (R-PA-1)· 2025-12-16
- Mike Kelly (R-PA-16)· 2026-01-08
- Donald G. Davis (D-NC-1)· 2026-01-12
- August Pfluger (R-TX-11)· 2026-02-02
- Blake D. Moore (R-UT-1)· 2026-02-02
- Thomas R. Suozzi (D-NY-3)· 2026-02-02
- Vicente Gonzalez (D-TX-34)· 2026-02-04
- Scott H. Peters (D-CA-50)· 2026-04-02
- Gus M. Bilirakis (R-FL-12)· 2026-04-09
- Henry Cuellar (D-TX-28)· 2026-04-09
- Lance Gooden (R-TX-5)· 2026-04-09
- Nathaniel Moran (R-TX-1)· 2026-04-09
- Jared Moskowitz (D-FL-23)· 2026-04-16
- Claudia Tenney (R-NY-24)· 2026-04-22
- Dan Crenshaw (R-TX-2)· 2026-04-27
- Eric Sorensen (D-IL-17)· 2026-04-27
- Mike Carey (R-OH-15)· 2026-04-27
- Pat Harrigan (R-NC-10)· 2026-04-29
Latest Action
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-07-07
Source: Congress.gov
Committee Activity
Currently in
- House Committee on Ways and MeansReferred To · 2025-07-07
- House Committee on Energy and CommerceReferred To · 2025-07-07
Previously
- Ways and Means CommitteeReferred To · 2025-07-07
- Energy and Commerce CommitteeReferred To · 2025-07-07
Plain-English Summary
This bill would protect patients' ability to access cancer treatments and other complex medications by limiting insurance companies' ability to deny or delay coverage for these therapies. It likely aims to reduce barriers that patients face when their doctors prescribe specialized drugs, such as requiring prior approval from insurers before treatment can begin. The measure would affect cancer patients, people with rare diseases, insurance companies, and healthcare providers.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Subjects
Health
Full bill text is not yet cached locally.
Related legislation
Bills by the same sponsor or covering overlapping subjects.
- HR8163Provider Reimbursement Stability Act of 2026Referred to Committee · 2026-05-21
- HR6583VA Research Reform Act of 2025Referred to Committee · 2026-05-20
- HR8553To direct the Secretary of Veterans Affairs to establish a precision oncology program for cancer of the prostate, and for other purposes.Referred to Committee · 2026-04-28
- HR8344Senior Citizens’ Freedom to Work Act of 2026Referred to Committee · 2026-04-16